David Larson

Horizon Therapeutics - / United States

Others

AD Scientific Index ID: 5361593

Registration, Add Profile,
Premium Membership

Print Your Certificate

David Larson's MOST POPULAR ARTICLES

1-) Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2DJ Jackson, WW Busse, LB Bacharier, M Kattan, GT O’Connor, RA Wood, ...Journal of Allergy and Clinical Immunology 146 (1), 203-206. e3, 20206412020

2-) BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformationA Bononi, C Giorgi, S Patergnani, D Larson, K Verbruggen, M Tanji, ...Nature 546 (7659), 549-553, 20173872017

3-) Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studySM Jones, EH Kim, KC Nadeau, A Nowak-Wegrzyn, RA Wood, ...The Lancet 399 (10322), 359-371, 20221802022

4-) Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesotheliomaA Napolitano, L Pellegrini, A Dey, D Larson, M Tanji, EG Flores, ...Oncogene 35 (15), 1996-2002, 20161822016

5-) Consensus report of the 2015 Weinman international conference on mesotheliomaM Carbone, S Kanodia, A Chao, A Miller, A Wali, D Weissman, A Adjei, ...Journal of thoracic oncology 11 (8), 1246-1262, 20161692016

ARTICLES

Add your articles